We developed a new generation of cell therapy products to regenerate articular cartilage damage: Cartibeads Vanarix has developed a new generation of cell therapy to produce high-quality hyaline cartilage mini-grafts, named Cartibeads, which resemble native tissue. Cartibeads are bio-engineered cartilage implant made from allogeneic chondrocytes. When implanted during minimally invasive arthroscopic surgery, Cartibeads can completely self-integrate into cartilage lesions and thus regenerate the tissue. Cartibeads are designed for the treatment of cartilage defects in traumatic and osteoarthritic joints. #cartilagerepair #cartilageregeneration #celltherapy #kneerepair #osteoarthritis

Type: Startup Activities: deeptech Technologies: Synthetic Biology

Delivering powdered, needle-free vaccines Orlance Inc is a company based out of Seattle, United States.

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology SaaS

.we create Quantum was designed to create technologies that solve concrete problems in cardiac surgery, cardiology and respiratory medicine. The primary objective of Quantum devices is to increase the safety of invasive procedures performed in worldwide cardiac surgical centers. First, we focus on highest volume procedures because supporting these will have the most significant impact on population health. We identify critical problems in medical procedures and therapy processes. We design the solution, organize specialist teams, and conduct the projects. Quantum uses scientific methodology to analyze and monitor the global market, population status, public health dynamics, progress in medicines, therapy guidelines, …

Type: Startup Activities: deeptech Technologies: Synthetic Biology

Leman Biotech, a spin-off company of EPFL, aims at developing and commercializing new metabolic cancer immunotherapies Leman Biotech is a clinical-stage cancer immunotherapy company co-founded by Professor Li Tang of the Swiss Federal Institute of Technology in Lausanne (EPFL) and XtalPi, a leader in AI-driven drug research and development. The company integrates innovative metabolic reprogramming technology with a cutting-edge AI drug discovery platform to develop next-generation cancer immunotherapies. Leman Biotech's Metabolic Reprogramming Technology (Meta 10) represents an innovative approach to combating T-cell exhaustion. Preclinical studies have demonstrated its ability to activate oxidative phosphorylation metabolism in terminally exhausted T cells, restoring …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Securing your vision Recornea is a clinical stage medtech ophthalmic company developing therapeutic solutions for treating diseases of the cornea, such as keratoconus, glaucoma and corneal transplants.

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Ethris is paving a new path from genes to therapeutic proteins using its proprietary messenger RNA technology platform. Ethris is paving a new path from genes to therapeutic proteins using our proprietary messenger RNA technology. Developed in-house, our integrated platform enables the discovery, design and development of transcript therapies that restore missing functions in patients’ cells and tissues. We will advance transcript therapies to transform the treatment of disease independently and with our partners. Biotechnology, mRNA, LNPs, Vaccines, Therapeutics, Formulation, and Manufacturing

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Predicting life-changing drugs for patients with cancer Calico Biosystems is on a mission to help pharma companies create effective, affordable drugs faster to counter cancer multi-omics assay, computational modeling, drug efficacy prediction, combination therapy, and Cell and virus-based therapeutics' efficacy

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

A UK-based, dermatology and oncology therapeutics company focusing on discovery and development of targeted solutions.

Type: Startup Activities: deeptech Technologies: Synthetic Biology

Exploiting a proprietary tech platform to develop biomolecular tools for therapeutic & synthetic biology applications PartitionBio Exploiting a novel proprietary technology platform to develop biomolecular tools for the use in therapeutic and synthetic biology applications. contact@partitionbio.co.uk

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Creating Tomorrow's Immunotherapies NXI therapeutics focuses on the research and development of a new generation of selective immunosuppressive drugs for autoimmune diseases and transplantations - with objectives of high efficacy, good safety without adverse effects as seen with conventional immunosuppressants.

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Fast and effective therapeutic debridement of burn injuries and chronic ulcers. SERDA Therapeutics is a joint venture between Smith & Nephew and NLC, focused on developing innovative wound care solutions. The company is dedicated to bringing to market a proprietary, best-in-class, fast-acting therapeutic product for burn injuries and chronic ulcers. SERDA has completed a Phase 1 Safety and Tolerability study in July 2024. This study was a blinded, randomized study that examined the immediate and 21-day cumulative irritation potential of ascending enzyme concentrations in SN514 hydrogel. The results confirm best-in-class potential for SN514 as the protection of “periwound” skin is …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

At UPSIDE Foods (formerly known as Memphis Meats), we're making your favorite food a force for good. Meat made from cells. We’re building the future you’re hungry for. *all meat shown is UPSIDE meat https://linktr.ee/upsidefoods Cultivated meat is new to many of us, and here at UPSIDE, we encourage education, learning, and fact-based debate. We ask that, in accordance with our values, you keep the conversation respectful to each other and to us. Thanks! cell culture, cultured meat, food science, food tech, meat, food, research and development, biology, process development, cell-based meat, and cultured meat

Type: Startup Activities: agritech biotech deeptech foodtech manufacturing Technologies: Synthetic Biology

Improve the lives of children with CNS diseases Lysogene is a biopharmaceutical gene therapy company with lead programs in neurodegenerative lysosomal storage disorders that affect children. Founded in 2009 by Karen Aiach, whose own child was affected by a neurodegenerative disease, Lysogene is rooted in a deep and compassionate understanding of the impact these diseases have on patients and families. Karen’s personal experience fuels her determination to deliver real solutions that will improve patient outcomes and enhance quality of life for both patients and caregivers. Over the past 10 years, Lysogene has acquired deep experience in developing gene therapies—from early …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

The leading online global destination for physicians and healthcare professionals: https://wb.md/2EPrMgZ Our Mission: To improve patient care with comprehensive clinical information and resources essential to physicians and healthcare professionals. Our Company: Medscape is the leading online global destination for physicians and healthcare professionals worldwide, offering the latest medical news and expert perspectives; essential point-of-care drug and disease information; and relevant professional education and CME. Medscape has over 30 distinct specialty sites for physicians, plus sites for nurses, pharmacists, dentists, and medical students. All content on Medscape.com and Medscape.org is available for free. medical news, medical reference, and continuing medical education

Type: SMB Activities: healthtech Technologies: Synthetic Biology

Get the backyard oasis you’ve always wanted with a Master Spas ultra-therapeutic hot tub or swim spa Master Spas is based in Fort Wayne, Indiana, 90 miles northeast of Indianapolis. Operating out of a state-of-the-art, 530,000-square-foot manufacturing facility on a 36-acre manufacturing campus, Master Spas is the largest swim spa manufacturer in the world, and largest portable hot tub manufacturer that makes 100% of our product in the USA. The company’s executive team boasts more than 200 years of spa manufacturing success and one of the strongest track records in the industry. The company is committed to helping people live …

Type: SMB Activities: edtech Technologies: Synthetic Biology

Helping youth and families with the challenges of growing and learning to achieve independence while realizing their full potential. Clinical Therapy, Group Homes, Sexual Exploitation, Crisis Stabilization, Special Needs Education, Drug Addiction, Independent Living, Young Parents, Mental Health, Foster Care, Sexual Abuse, and Employment Training

Type: SMB Activities: edtech healthtech Technologies: Synthetic Biology

Been There. Outdone That.TM Jelmar manufacturers CLR Brands and Tarn-X branded cleaning products. These products are available in food, drug and mass retailers. Jelmar has been a growing, evolving company since its inception in 1949. The company began when Manny Gutterman established a national sales representative organization, Manny Gutterman & Associates, Inc. This new company was dedicated to selling all types of proprietary products to chain drug, variety, hardware and department stores. Tarn-X® Tarnish Remover, during the late 1960s, became one of the first products that used the phrase “AS SEEN ON TV” in commercials and on packaging. Tarn-X has …

Type: SMB Activities: deeptech manufacturing Technologies: Synthetic Biology

Enhancing human life and shaping the future world by creating inclusive innovations to make a positive impact. 🏔 Explore beyond possible. 🦿 Enhancing human life and shaping the future world by creating inclusive innovations to make a positive impact. Product design, Medical devices, Innovation design engineering, Innovation, Parkinson's, Diabetes, Gait disorders, Data science, and Remote monitoring

Type: Startup Activities: healthtech biotech deeptech Technologies: Synthetic Biology

Leading the way in flexible material converting by solving and serving the challenges and needs of our global customers. A medical flexible material converter and contract manufacturer serving global medical device and healthcare companies. From material slitting and die cutting through to lamination and printing, we are able to provide a full end-to-end solution for simple and complex projects. PolarSeal is solely focused on medical device contract manufacturing and healthcare material conversion. Maintaining the highest standards of quality is part of who we are and this fortifies our value of being the TRUSTED ADVISOR. Get in touch : enquiries@polarseal.net Wound …

Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

Winners of Innovate UK Smart Award | Buckingham owns over 12 patented products and 10 international trademarks Established in 2003 – Buckingham Healthcare are an innovative designer and manufacturer of aids to daily living and healthcare related products based in Dorset. At Buckingham Healthcare you will find a growing range of products some of which are unique and brand new to the market and others which are long established favourites. Whatever your needs you can be confident that you are dealing with qualified healthcare professionals who will be able to provide you with knowledgeable answers to any of your questions …

Type: SMB Activities: healthtech manufacturing deeptech Technologies: Synthetic Biology

A CALIBRE SCIENTIFIC COMPANY Molecular Dimensions is a supplier of modern screens and reagents for protein structure determination by X-ray crystallography. We stock a wide variety of products for protein crystallography including bacterial growth media, ready-to-use selenomethioine expression media, crystallization screens, crystallization plates and cryocrystallography. We also supply crystal growth incubators and automated solutions for crystal growth imaging and analysis with UV fluorescence. Owing to our comprehensive range of products we are widely recognised as the world leader in membrane protein crystallization. Have any questions? Contact us at enquiries@moleculardimensions.com! Protein Crystallography, Structural Biology, Protein Expression Media, Custom Products, SILAC media, …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Hyderus is proud to be a part of FINN Partners. For all future updates, please visit the website. Hyderus - A FINN Partners company is a specialised consultancy in four areas of communications and policy: 1. The rapid change in how decisions are made about health in Europe and other industrialised societies and how clients can influence these decisions 2. The evolution of public health issues in developing countries; how clients can help to inform the discussion on these problems and; how clients can become involved in finding answers 3. Public thinking about international political and development issues - especially …

Type: SMB Activities: consulting Technologies: Synthetic Biology

Creating class-leading ADCs with enhanced tumor specificity Through our highly experienced ADC Research & Development Team, we are building a pipeline of class-leading ADCs with superior therapeutic index (TI) for difficult-to-treat cancers. Our approach is to develop the best ADC for any given target or tumor sub-type rather than 'technology-driven ADCs'. All our ADCs incorporate tumor-selective release & activation of the most relevant payload according to mechanism, optimizing anti-cancer efficacy and enhancing patient safety. Antibody-Drug Conjugates, PermaLink™, Conjugation Chemistry, Cancer research, ADCs, Drug Development, Therapeutics, Antibodies, Toxins, Cancer Treatment, ADC Stability, Antibody Drug Conjugate, Drug Discovery, Biotechnology, Preclinical, Bioconjugation, Organic …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

At Proclinical Staffing, our life science recruitment services support our partners with permanent and contract vacancies by connecting them with specialist talent across the globe. Whether you are looking for a recruitment agency to support you with a single vacancy or you need to staff an entire new facility, we extend an expert hand to help you find the highly-skilled people you need. Operating exclusively within life sciences industry – from MedTech and Medical Devices to Pharma and Biotech – our experience, resources and dedication enable us to meet the unique needs of the competitive, fast-paced industry. Our worldwide connections …

Type: SMB Activities: healthtech regtech deeptech biotech hrtech Technologies: Synthetic Biology

Delivering economic impact by helping small businesses to innovate, compete and grow across the North of England. RTC North is an independent company with a 34-year track record in helping organisations to innovate, compete and grow. Established in Sunderland in 1989 as one of 12 ‘Regional Technology Centres’, its advisors have since worked with over 25,000 businesses across the North of England on a one-to-one basis to drive innovation, business improvement, and growth. The company employs over 100 staff and its team possess multi-disciplinary and multi-sector backgrounds and is made up of entrepreneurs, technologists, engineers, scientists, and researchers. The company …

Type: SMB Activities: consulting legaltech martech Technologies: Synthetic Biology

MUSCLE MILK is a company based out of 4a Crown Road, Stoke On Trent, United Kingdom.

Type: SMB Activities: healthtech Technologies: Synthetic Biology

Because Not Everything in Life is Black and White We are a long established and experienced translation agency specialising exclusively in medical and pharmaceutical documentation. We have been providing top-quality translations since 1999, the year we formed. Zebra is a member of the Association of Translation Companies (ATC) and Federation of Small Businesses (FSB). Our senior in-house linguists are individual members of the Institute of Translation & Interpreting (ITI) and/or the Chartered Institute of Linguists (CIOL). If there's anything else you would like to know, please visit www.zebratranslations.uk or please call us on +44 (0) 1462 429713, we shall be …

Type: SMB Activities: healthtech regtech deeptech Technologies: Synthetic Biology

Building a healthier nation. At Highgate Hospital, we provide you with rapid access to London’s top Consultants across a wide range of medical & surgical specialities. With the support of our patient services & nursing teams, we are there to support you every step of the way – from consultation to treatment and aftercare. We are a leading hospital based in leafy Highgate, North London. Rated OUTSTANDING in the well-led domain and GOOD overall by the CQC, we are proud of our high standards of nursing care, clinical excellence, cutting edge technology and friendly atmosphere for patients. Our Mission Our …

Type: SMB Activities: healthtech deeptech biotech Technologies: Synthetic Biology

Innovation in Diagnostics SureScreen Diagnostics believe that early, accurate diagnosis is better than waiting for problems to arise, and a proactive approach greatly benefits people's health, identifies issues early in their development, prevents accidents from happening and has a positive effect on performance, productivity and reputation. Our mission is to provide the best quality diagnostic products that meet and exceed their customer's expectations at a fair price. SureScreen Diagnostics is an award-winning business that manufactures testing kits to be used by the patient side, which delivers quick and reliable results. Established in 1996, SureScreen has been providing proactive, bespoke diagnostic …

Type: SMB Activities: healthtech Technologies: Synthetic Biology

Revolutionizing the storage and delivery of vaccines and therapeutics. We are a biotechnology company revolutionizing vaccines and biologics by removing all cold storage requirements and expediting manufacturing.

Type: Startup Activities: deeptech Technologies: Synthetic Biology

Eat me, lick me, spoon me, but never bore me. Nick’s - Surprisingly craveable. Nick’s does some of the yummiest sweets, ice cream and protein bar down, but that’s not all. Our purpose is larger than that. We eliminate the gap between indulgent and healthy, through food innovation, to empower more people to make better food choices. Nick’s exist for the impulsive, the yay-sayers and the uncommitted. Always know that you have a friend in Nick’s, flake more, play more and stay yummy. So, eat me, lick me, spoon me, but never bore me. Nick’s - Surprisingly craveable. Konfektyr, Confectionery, …

Type: Startup Activities: foodtech Technologies: Synthetic Biology

We simplified protein. Nature perfected the taste. Experience our sunflower proteins difference! At Sunbloom Proteins, we love food and we have the mission to support people in their food transition towards more plant-based diets. Our core business activity consists in producing and marketing functional and nutritional proteins from sunflower seeds as an ingredient for food. Our patented sunflower protein ingredient delivers unique features in terms of nutrition (60% protein content, 20% fiber content), functionality (emulsification and foaming properties) as well as sensory profile (neutral taste profile - no off-note, clean off white color). On top of that, our sunflower proteins …

Type: Startup Activities: foodtech Technologies: Synthetic Biology

Better Protein from Upcycled Plants Made from Upcycled Plants plant based meat and foodtech

Type: Startup Activities: foodtech Technologies: Synthetic Biology

Interactive Shivors Inmersiv Technologies is a company specializing in the development of technological and therapeutic tools based on sensory stimulation. Wellness, Innovation, Technology, Ehealth, and Startup

Type: Startup Activities: it services Technologies: Synthetic Biology

Let’s cure from the beginning! Genome editing-based therapies become the predominant technology of the 21st century with promising statements about genetic diseases treatments. Genome editing tools recently emerged but they suffer from an absence of standardization and their applications remain limited. In this context, Quidditas developed a novel genome editing platform which permits an absolute genetic recombination. Compatible with a larger scope of applications, from bioprocess improvement to genetic disorders treatment, this revolutionary technique will have a major impact in the synthetic Bio field. So “Let’s cure from the beginning!” Genome Editing

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Our Somatic Genomics platform unveils a new universe of genetic variation to create transformational medicines. Learn more at Quotient-Tx.com

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions. VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions for large disease areas of high unmet medical need. By combining state-of-the-art technologies and novel and scientific concepts, VectorY’s mission is to bring innovative therapies to patients worldwide. Founded in August 2020, and based in the Amsterdam Science Park, VectorY is a fully integrated gene therapy company focused on the development of innovative therapeutics such as vectorized antibodies for both CNS and somatic disorders, with a special focus on muscle …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

At Bioharmony Therapeutics, we are developing nontraditional antimicrobial therapeutics by exploiting millions of years of phage-bacteria evolution. Our focus is on targeting infectious diseases caused by multidrug-resistant (MDR) Gram-negative bacteria. Our primary therapeutic indication is for Acinetobacter baumannii skin and wound infections.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

#notblood GraphWear is a San Francisco based technology company that diagnoses and monitors chronic diseases continuously without any blood or urine. GraphWear's needle free continuous glucose monitoring system is currently being tested in the clinic for diabetes management. Nanotechnology, Non-invasive healthcare monitoring, Preventive healthcare, medical device, Wearable diagnostics, and continuous monitoring

Type: Startup Activities: healthtech deeptech nanotech Technologies: Synthetic Biology

Addressing the problem of natural repair of soft tissues with injectable 3D scaffolds Volumina Medical is a multi-award-winning start-up active in the field of medical devices supported by a solid network of investors. The company develops breakthrough innovations for plastic and reconstructive surgery. The first product is an implantable polymeric biomaterial and targets the regeneration of soft tissue of the human body which are damaged after tumor excision, genetic malformation or trauma. Implants, Biomaterial, and Regenerative Medicine

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

IRT, eConsent, eCOA, and ePatient solutions to help you wisely guide novel science through complex clinical trials Suvoda is a global clinical trial technology company specializing in complex, life-sustaining studies in therapeutic areas like oncology, central nervous system (CNS), and rare diseases. Suvoda empowers sponsors, sites, and patients to manage the most urgent moments in the most urgent trials through advanced IRT, eConsent, eCOA, and ePatient software solutions delivered on a single platform. Clinical trial management, Interactive response technology, Subject randomization, Trial supply management, IWRS, IRT, Interactive Web Response System, Clinical Supplies, Patient Logistics, Clinical Supply Logistics, eCOA, ePatient, Clinical …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Developing novel treatments at the forefront of oncology Ryvu Therapeutics is a clinical-stage drug discovery and development company focused on novel small molecule therapies that address emerging targets in oncology. Internally discovered pipeline candidates make use of diverse therapeutic mechanisms driven by emerging knowledge of cancer biology, including small molecules directed at kinase, synthetic lethality, and immuno-oncology targets. Ryvu’s most advanced programs are RVU120 - a selective CDK8/CDK19 kinase inhibitor with potential for the treatment of hematological malignancies and solid tumors currently in Phase I clinical development for the treatment of acute myeloid leukemia and myelodysplastic syndrome, and Phase I/II …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Mapping the druggable transcriptome An estimated 85% of the ~3 billion base pairs in the human genome is transcribed into RNA, but only ~1.5% of these code for proteins. While the chemical properties of protein binders are increasingly understood and interrogated, the field of RNA-targeted drugs is relatively new and the properties of small molecules that drive specific and selective targeting of RNA, and associated assays, are yet to be developed. At Serna Bio [previously Ladder Therapeutics] we are using an AI enabled, data-first approach to write the rules that define RNA-small molecule interactions. Our Discovery Platform powers our first-in-class …

Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Synthetic Biology

Foghorn Therapeutics is pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, an untapped opportunity for therapeutic intervention. Our proprietary Gene Traffic Control® platform gives us an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing us to identify, validate and potentially drug targets within the system.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Pushing the boundaries of gene therapy to develop treatments for debilitating neurodegenerative diseases. Sio Gene Therapies combines cutting-edge science with bold imagination to develop genetic medicines that aim to radically improve the lives of patients. Our current pipeline of clinical-stage candidates includes the first potentially curative AAV-based gene therapies for GM1 gangliosidosis and Tay-Sachs/Sandhoff diseases, which are rare and uniformly fatal pediatric conditions caused by single gene deficiencies. We are also expanding the reach of gene therapy to highly prevalent conditions such as Parkinson’s disease, which affects millions of patients globally. Led by an experienced team of gene therapy development …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Making the hope of early detection, a reality. Meet the team behind iBreastExam and cervAIcal! UE LifeSciences is a fast-growing, multi-national med-tech company bringing the promise of early detection of cancer to women globally. Our innovations have reached more than 250,000 women in 12 countries. We've grown revenue five-fold in the past three years with distribution in 10 countries and counting. And we've raised over $6 million in grants, international awards and equity capital! Our work is featured on platforms such as TED Talks and notable publications such as The New York Times, BBC World News, Forbes and others. Medical …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

OvaScience, Inc. (NASDAQ:OVAS) is a company focused on the discovery and development of new treatment options for women and families struggling with infertility. Each OvaScience treatment is based on the Company’s proprietary technology platform that leverages the breakthrough discovery of EggPC cells – immature egg cells found within the outer ovarian cortex. OvaScience is developing OvaPrime, a potential fertility treatment that could help restore a woman’s egg production, and OvaTure, a potential fertility treatment that eliminates the need for hormone stimulation. OvaScience’s AUGMENT treatment, designed to improve fertilization and pregnancy rates, is available in Japan under an exclusive license to …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Personalized, clinically-based virtual and in-person solutions for total well-being. SimpleTherapy provides physical, MSK, and behavioral health services that combine digital and technology-guided treatment with a national network of in-person and telehealth providers. At our core is a commitment to providing inclusive, holistic care that is simple, accessible, and personalized. Our clinically backed, innovative solutions support the overall health of your workforce and reduce costs for all parties. Our clients include employers of all sizes, major health plans, and Fortune 50 organizations. SimpleTherapy, where improved health meets simplicity. Notable Media Coverage: - The New York Times: http://nyti.ms/1ivhBZC - The Huffington Post: …

Type: Startup Activities: healthtech Technologies: Synthetic Biology

Delivering better health 1-1 via an empathy-first Peer workforce Health plans, health systems, and employers leverage our Peer workforce (tech-enabled remote workforce of community health workers) to engage struggling patients (with empathy!) and help them address SDoH barriers, activate healthy behaviors and improve clinical outcomes. peer support, peer mentoring, community health workers, diabetes, asthma, prediabetes, sickle cell, hypertension, digital health, and coaching

Type: Startup Activities: healthtech biotech deeptech Technologies: Synthetic Biology

Synthorx, Inc. is a biotechnology company focused on prolonging and improving the lives of people with cancer and autoimmune disorders. Synthorx’s proprietary, first-of-its-kind Expanded Genetic Alphabet platform technology expands the genetic code by adding a new DNA base pair and is designed to create optimized biologics, referred to as Synthorins. A Synthorin is a protein optimized through incorporation of novel amino acids encoded by the new DNA base pair that enables site-specific modifications, which enhance the pharmacological properties of these therapeutics. The company’s lead product candidate, THOR-707, a variant of IL-2, is in development in multiple tumor types as a …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Better Breeding Today. Brighter Life Tomorrow. Hendrix Genetics is a leading multi-species animal breeding company with primary activities in layer-, turkey-, traditional poultry-, swine-, trout and salmon breeding. Backed by a strong portfolio of leading brands, Hendrix Genetics provides expertise and resources to producers in more than 100 countries, with operations and joint ventures in 24 countries and more than 2.880 employees worldwide. Creating value with genetics is the essence of our existence. The three key components of how we create value for the animal protein chain are: collaboration, innovation and sustainability. We see collaboration as a key factor in …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

The Cell Therapy Venture Builder MedXCell is a European cell therapy venture builder with a strong industrial mindset and a global perspective. Our focus is on technologies, techniques or novel applications in major diseases such as cancer, autoimmune, neurological and degenerative disorders. Established in 2018, we have offices in Switzerland, the EU (France) and the US (Cambridge, MA) and a multidisciplinary expert team with entrepreneurial, clinical, operational, business development and funding capabilities. Biotechnology, Cell Therapy, Immunotherapy, NK Cells, Mesenchymal Stromal Cells, Immuno-oncology, and Osteoarthritis

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Pioneering Possibility® For 32 years, Device Technologies has supplied the Australian healthcare community with quality and technologically advanced medical equipment, consumables, education and service. Proudly Australasian-owned, the company continues to grow, now employing more than 1000+ healthcare specialists and support staff across Australia, New Zealand, and Asia. In 2025, Device Technologies remains dedicated to the mission of enabling superior health outcomes for patients and their healthcare providers, by facilitating access to the best medical technology available worldwide. The company is united in its four core values to innovate, collaborate, take ownership, and consistently conduct good business. The extensive Device Technologies …

Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

Genenta is a clinical stage immuno-oncology company Genenta (Nasdaq: GNTA) is a clinical stage immuno-oncology company developing a proprietary hematopoietic stem cells therapy for the treatment of a variety of solid tumor cancers. Genenta's first in class product candidate is TemferonTM, which is designed to allow the expression of immune-therapeutic payloads within the tumor microenvironment by bone marrow derived myeloid cells and enable a durable and targeted response. Genenta has completed a Phase 1 trial for newly diagnosed Glioblastoma Multiforme patients with an unmethylated MGMT gene promoter, which suggests the potential reprogramming of the tumor microenvironment and inhibiting of myeloid …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Improving life for cancer patients through transformative drugs Medivir develops innovative drugs with a focus on cancer where the unmet medical needs are high. The drug candidates are directed toward indication areas where available therapies are limited or missing and there are great opportunities to offer significant improvements to patients. Medivir is focusing on the development of fostroxacitabine bralpamide (fostrox), a smart, targeted chemotherapy designed to selectively treat liver cancer cells and to minimize side effects. Collaborations and partnerships are important parts of Medivir's business model, and the drug development is conducted either by Medivir or in partnership. Medivir's share …

Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Providing essential, standardized tools to accelerate breakthroughs in human health Microfluidics | Cytometry | Imaging Standard BioTools delivers the leading proteomic and multi-omic solutions that enable researchers to discover unique biological insights not accessible by other technologies. Mass Cytometry, Tissue Imaging, NGS Library Prep, Genotyping, Gene Expression, Copy Number Variation, Real-Time PCR, and Single-Cell Genomics

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

A South Korea-based medical devices company that offers innovative technology to streamline diabetes care management EOPatch(Wearable Insulin Pump) Manufacturer

Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

Empowering Self-Care in Europe Established in 1964, the Association of the European Self-Care Industry (AESGP) represents the manufacturers of non-prescription medicines, food supplements and self-care medical devices (an area also referred to as consumer healthcare products). Our mission is to advance responsible self-care, enabling citizens to take better care of their health needs, and to contribute to the sustainability of European healthcare systems. OTC, Substance based MD, Non-prescription medicines, Pharmaceutical, Self-care, and Food supplement

Type: SMB Activities: foodtech healthtech manufacturing Technologies: Synthetic Biology

Protein Sciences (www.proteinsciences.com) is a biotechnology company that specializes in vaccine development and protein production. Our mission is our inspiration: to save lives and improve health by effectively responding to the changing world through the creation of innovative vaccines and biopharmaceuticals. See where Flublok® Influenza vaccine is available at www.flublok.com. We use our proprietary BEVS protein expression technology to produce high quality recombinant proteins quickly, reliably and at low cost. We have developed three main business lines that employ this technology: 1. Proprietary vaccines - we develop and produce the next generation of safer and more effective vaccines 2. GeneXpress® …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

We Chase the Miracles of Science to Improve People’s Lives. Sanofi is an innovative, global biofarmaceutical company, which is guided by one goal, so that according to the slogan "We Chase the Miracles of Science to Improve People’s Lives", focusing on the power of science, change the world for the better. In 100 countries, the teams involved and talented work to change the face of medicine, making impossible possible. The company creates therapies and vaccines that save lives to millions of people around the world. We have a wide range of specialized medicinal products and services in many therapeutic areas …

Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

An IRO committed to better access to clinical research, the development of new medicines, and health equity. Circuit Clinical, one of the fastest-growing research networks in the USA, is dedicated to empowering patients to choose clinical research as a care option through improved access to clinical trials. Committed to transforming the experience of finding, choosing, and participating in clinical research for physicians and their patients, Circuit provides clinical research services through traditional, hybrid, and decentralized community-based site models and their MD Prescreen service that optimizes patient referrals. Learn more at circuitclinical.com Clinical Research Enrollment Solutions, Patient Recruiting Services, Clinical Site …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Building the world's most advanced generative AI platform for peptide therapeutics design. Menten AI is a drug discovery company focused on designing peptides for conditions with high unmet medical need. We are developing the world's most advanced generative AI platform for peptide therapeutics.

Type: Startup Activities: deeptech Technologies: A.I. A.I. - Machine Learning Generative A.I. Synthetic Biology

Innovation in Spirometry, Oximetry & E-Health A Made in Italy story worth telling: with your breath for over 30 years. At MIR - Medical International Research, we develop premium medical equipment, including spirometers, oximeters, and cardiac monitors for professional and personal use to manage and prevent respiratory conditions. Founded in Rome in 1993, MIR has been an ambitious dream since its inception: to promote early diagnosis and monitoring of respiratory diseases to everyone... anytime, anywhere! With 4 offices in the world in Italy, North America, France, and Brazil, and a robust distribution network, our products are available in over 100 …

Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

Dedicated to understanding the intricacies and power of the immune system; striving toward a Life Without Disease ®. "Sometimes in science there are so many people trying to answer the same question that it's good to stray off in another direction,"​ Mitchell Kronenberg, Ph.D., LJI Professor. "Taking the road less traveled can bring its voyagers to unexpected - and even groundbreaking - new territory."​ The La Jolla Institute The La Jolla Institute for Immunology is a non-profit medical research institute dedicated to increasing knowledge and improving human health through studies of the immune system. Our essential purpose is to expand …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Created in 2007, Vet’eau is a veterinary firm recognized for its expertise in the aquaculture environment in France and abroad. Our activity relates to all areas of aquaculture: freshwater fish farming, marine farming, ornamental fish, ... Our team is made up of specialized veterinarians, engineer and laboratory workers as well as an administrative center in direct contact with customers. Present in more than 15 countries, we offer several multidisciplinary services: laboratory analysis, health management and biosecurity, ... Aquaculture, laboratory analyzes, health management, biosecurity, health prophylaxis, veterinary products, veterinary equipment, freshwater fish farming, marine breeding, ornamental fish, shell, research center, vaccines, …

Type: SMB Activities: pettech it services Technologies: Synthetic Biology

Making personalized healthcare possible for individuals, healthcare providers, benefit administrators and employers. Pharmacogenomics (PGx) is the next frontier in medication therapy management and RxGenomix was created specifically to help put it to work for everyone. RxGenomix helps healthcare providers understand the genetic-driven mechanisms behind the response to medications and navigate the implementation process of a new healthcare tool. By applying PGx testing, they can look at very specific pieces of their patients’ DNA to know, for many of the most common and critical medications, precisely which might be best for that individual, and at what dosage. Empowering healthcare providers with …

Type: Startup Activities: healthtech Technologies: Synthetic Biology

Connected, Reusable Drug Delivery Portal Instruments is a Series C funded medical device company focused on advanced drug delivery and backed by strategic and venture investors. We are developing and commercializing a highly innovative needle-free drug delivery platform technology to transform the administration of medicines and improve the patient experience for those with chronic disease who inject themselves. Portal’s needle-free delivery technology is derived from research at MIT and enables the administration of high viscosity biologic drugs with less discomfort and without the anxiety of handling needles. Using precise pressure technology, the injection is administered through the skin via a …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Seeking to improve lives through the curative potential of gene therapy. REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the development of AAV Therapeutics, an innovative class of gene therapy medicines. REGENXBIO is advancing a pipeline of AAV Therapeutics for retinal and rare diseases, including ABBV-RGX-314 for the treatment of wet AMD and diabetic retinopathy, being developed in collaboration with AbbVie, RGX-202 for the treatment of Duchenne and RGX-121 for the treatment of MPS II. Thousands of patients have been treated with …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology SaaS

Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health and change how brain disorders are thought about and treated. Our mission is to pioneer solutions with the potential to deliver life-changing brain health medicines, so every person can thrive. Welcome To The Workplace With A Difference At Sage, we believe that life is more …

Type: Startup Activities: healthtech biotech deeptech Technologies: Synthetic Biology

POWER OVER FOOD ALLERGIES Aimmune Therapeutics, Inc., a Nestlé Health Science Company, is a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies. With a mission to improve the lives of people with food allergies, Aimmune is developing and commercializing oral treatments for potentially life-threatening food allergies. The Company’s Characterized Oral Desensitization ImmunoTherapy (CODITTM) approach is intended to provide meaningful levels of protection against allergic reactions resulting from accidental exposure to food allergens by desensitizing patients with defined, precise amounts of key allergens. Aimmune has one FDA-approved medicine for peanut allergy and other investigational therapies in development to …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Prapela is a breakthrough noninvasive stimulation therapy that naturally improves breathing and oxygenation in newborns. Prapela is a breakthrough noninvasive stimulation therapy that naturally improves breathing and oxygenation in newborns. Based on a field of science called Stochastic Resonance, our precise and gentle stimulation improves breathing rhythm and lung function in newborns. Since 2017, we've received over $8M in awards and grants funding the clinical evaluation of our therapy to improve the treatment of opioid-exposed newborns and preterm infants with apnea of prematurity. Next, we aim to improve the treatment of preterm intermittent hypoxemia and bronchopulmonary dysplasia. For more information, …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Decoding Biology to Radically Improve Lives We are a clinical-stage TechBio company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering to industrialize drug discovery. We are leveraging new technology to create virtuous cycles of learning around datasets to build the next-generation biopharmaceutical company. It’s complex biology, decoded. While we are united in a common mission, Decoding Biology to Radically Improve Lives, our greatest strength lies in our differences: expertise, gender, race, disciplines, experience, and perspectives. Deliberately building and cultivating this culture is critical to achieving our audacious goals. We are proudly headquartered in Salt …

Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Synthetic Biology

Superpulsed therapeutic lasers: Lumix 2 Series, Superpulsed + CW therapeutic lasers: Lumix 3 Series, Superpulsed + CW therapeutic lasers: Lumix 4 Series, Lumix Lasers, drug free pain relief, pain relief, laser therapy, alternative medicine, Chiropractic, dentistry, physical therapy, pain management, superpulsed lasers, therapeutic lasers, sports medicine, medical devices, and technology

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Verastem Oncology (Nasdaq: VSTM) (Verastem, Inc.) is a late-stage development biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with RAS/MAPK pathway-driven cancers. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition, FAK inhibition and KRAS G12D inhibition. Pursuing unexplored pathways demands that we’re purposeful in everything we do. And it’s an endeavor that’s only possible with an experienced team of employees and partners dedicated to a singular purpose: changing and improving the …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Better materials for better products Lygos is a pioneering sustainable specialty chemicals company, leading the world’s transition toward better, cleaner, and more sustainable products. We have built a proprietary and fully integrated platform of the most advanced technologies across synthetic biology, industrial chemistry, and application development to rapidly deliver market relevant solutions to some of the world’s biggest sustainability challenges. With a pipeline of high-performing, innovative solutions, Lygos is paving the way for generations of new sustainable solutions for our world. Synthetic Biology and Specialty Chemicals

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Beautifully designed and clinically validated digital medicine and digital therapeutics (DTx) solutions Newel Health represents a novel category of innovative companies whose mission is to develop and commercialize beautifully designed and clinically validated digital medicine and digital therapeutics (DTx) solutions in partnership with pharmaceutical and medical device companies and other health and wellness stakeholders. Built on a strong heritage in health innovation Newel Health leverages data and technology to future-proof healthcare, while putting human empathy and patients’ and HCPs’ actual needs at the center of all its products.

Type: Startup Activities: healthtech Technologies: Synthetic Biology

Making cannabinoids accessible What our ancestors instinctively knew and through centuries -old traditions also proves more and more scientific research: the active ingredients of the Cannabis sativa plant, the so -called cannabinoids, show many positive effects in use for medical purposes, such as chronic pain and epilepsy. But also in the area of ​​cosmetics and the nutritional supplements, ingredients of the cannabis sativa plant are increasingly used. Synbiotic se pursues the goal of mapping the entire value chain of the cannabis sativa plant for the benefit of the people: from basic research to the synthetic production of these substances to …

Type: Startup Activities: healthtech Technologies: Synthetic Biology

Transform how you model human biology. Elixirgen Scientific is a global leader in regenerative medicine and biotechnology, headquartered in the Science + Technology Park at the Johns Hopkins Medical Campus in Baltimore, MD. Our mission is to advance science and medicine with fast, functional, and scalable induced pluripotent stem cell (iPSC) differentiation products and services. Our state-of-the-art, transcription-factor-based technology allows you to overcome the high cost and inefficiencies associated with lengthy cell differentiation periods. We empower research institutions, pharmaceutical organizations, and biomedical enterprises worldwide, even those with no previous iPSC experience, by increasing access to relevant cells for modeling human …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Driven by the heart We officially combined with Bristol Myers Squibb to further strengthen our scientific capabilities and treatments for cardiovascular patients. Visit www.bms.com to learn more about our work to produce the next generation of medicines for patients with serious cardiovascular disease. For more information on the acquisition, see our press release at: https://one.bms.com/40FsT7W Genetic Heart Disease, Cardiomyopathy, biotechnology, cardiovascular disease, heart failure, precision medicine, therapeutics, drug discovery, drug development, and R&D

Type: Startup Activities: healthtech biotech deeptech Technologies: Synthetic Biology

Geltor is the biodesign company powering the products of the future with effective, sustainable, animal-free proteins Geltor is the biodesign company that audaciously imagines and deeply explores all the possibilities that the tree of life has to offer. With customer benefit at the fore of each step of the creative process, Geltor has created the largest selection of designer proteins that are crafted with unparalleled biocompatibility and functionality. These proteins are 100% animal- and GMO-free, globally scalable, and sustainably cultivated. Geltor’s products are the result of endless curiosity and ceaseless optimization, clinically demonstrated for high performance. Biotechnology, Protein, Cosmetics, Personal …

Type: Startup Activities: deeptech fashtech biotech healthtech Technologies: Synthetic Biology

DIANA Biotechnologies: Diversified Biotech We are leading Czech biotechnology company with a great innovative potential. We focus on the development of products based on our cutting edge research in the fields of molecular diagnostics and drug discovery. We have global ambitions and since our foundation in 2018 we already have achieved some of our goals. During COVID-19 pandemics, we were able to quickly develop one of the most innovative COVID-19 tests worldwide and we helped to increase the testing capacity of the whole country. As a result, we became the biggest Czech manufacturer of RT-PCR tests. Besides RT-PCR, we continue …

Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Bridging the treatment gaps in veterinary care for companion animals TriviumVet are an animal therapeutics company headquartered in Waterford, Ireland. We work with human healthcare and pharmaceutical businesses to bring healthcare applications to the veterinary market including: - veterinary pharmaceuticals, - veterinary medical devices and - veterinary diagnostic solutions Our pipeline includes patented, proprietary technology and pharmaceuticals that are completing European Medical Agency and Food and Drug Administration regulatory pathways. We develop in house research but also work with leading human healthcare companies. You can follow us online @triviumvet on Facebook, Twitter and Linkedin veterinary, pharmaceuticals, research and development, innovation, …

Type: Startup Activities: pettech biotech deeptech healthtech Technologies: Synthetic Biology

Made With Empathy THEYA Healthcare designs and manufactures garments that promote healing, offer exceptional comfort and functionality, and look beautiful. Our bras and briefs are clinically proven to have a positive impact on body image, improve quality of life and help heal and alleviate pain. Founded in 2015, Theya Healthcare was originally established to fulfill an unmet need in women's breast cancer health. Our female designers created the original patented bamboo post-surgery bra. To this day, we remain the only post-surgery bra, clinically proven to help women heal and feel better faster after breast cancer surgery. We use the finest …

Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

Clinical CRISPR and Gene Therapy of the Microbiome Company We are the CRISPR and Gene Therapy of the Microbiome company! Precision killing of bacteria has the impact to revolutionise the management of untreatable and difficult-to-treat infections as well as complex diseases directly impacted by the human microbiota. Our mission is to develop CRISPR-based medicines that give hope for effective and safe treatment of difficult-to-treat diseases in the future.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Clinical stage fibrosis and cancer treatments Galecto is a clinical stage biotechnology company committed to the development of novel small molecule therapeutics directed at biological targets which are at the heart of fibrosis, inflammation, and cancer. Galecto was founded by leading fibrosis-focused scientists and biotech executives and is built on more than 10 years of research into galectin and fibrosis modulators. Our team has developed a deep understanding of the galectin family of proteins and the LOXL2 enzyme, and how both influence multiple biological pathways of these complex, often devastating, diseases. Galecto is funded by Novo Holdings, OrbiMed, Ysios, HBM …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Creating Drugs at the Speed of Ai Absci is a data-first AI drug creation company designing differentiated therapeutics using generative AI. Our Integrated Drug Creation platform powers cutting-edge de novo AI models and AI lead optimization models aimed at designing better biologics against difficult-to-drug targets. generative AI, synthetic biology, biologics, drug discovery, antibody development, artificial intelligence, pharmaceuticals, and biotechnology

Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Deep Learning Generative A.I. Synthetic Biology

The Positively Addicting Bold Bean Chip. Beanfields is on a mission to inspire the world to upgrade their snacking habits with crunchy, mouth-watering BEAN-BASED chips that are POSITIVELY ADDICTING and deeply nutritious. Every bag of Beanfields chips is full on flavor, packed with protein and fiber, Non-GMO, gluten free, and vegan. Finally, an addiction you can feel good about. Beanfields are currently sold throughout all 50 states, Canada, and other countries. We have a unique social impact partnership with Homeboy Industries, the largest and preeminent gang rehabilitation and re-entry program in the world. Bean and Rice Chips, Gluten-Free Snacks, Vegan …

Type: Startup Activities: foodtech Technologies: Synthetic Biology

Service robots for business Promobot is the largest service robotics manufacturer in Europe. We work in the fields of mechatronics, AI, and neural networks. Our developments include autonomous navigation, dialogue systems, manufacturing of artificial skin and muscles. Promobot creates humanoid and service robots, while also engaging with human-machine interaction as a whole. Promobot robots operate in 40 countries around the world. Their line of work includes interaction with people at events, customer assistance, management of internal systems, and patient assessment for hospitals. Robotics, AI, Hardware, Software, Industry, IT, and Engineering

Type: Startup Activities: it services manufacturing Technologies: A.I. A.I. - Deep Learning Robotics Synthetic Biology

We are a non-profit medical and scientific organisation for cellular and stem cell-based therapies. Join our community! The EBMT is a non-profit medical and scientific organisation established in 1974 which hosts a unique patient registry providing a pool of data to perform studies and assess new trends. We aim to be the connection between patients, researchers and other stakeholders to anticipate the future of cellular and stem cell-based therapies. Our community of healthcare professionals is focused on innovation, research and the advancement of these fields to save and improve the lives of patients with blood-related disorders. Visit www.ebmt.org to learn …

Type: SMB Activities: edtech Technologies: Synthetic Biology

Providing innovative quantum and AI solutions for drug discovery and design. Our discovery platform uniquely combines target quantum mapping and AI led chemistry to enable faster development of better drug candidates. Our unique approach tackles common challenges in both AI driven drug design and target driven drug discovery. Quantum Mapping of targets introduces selectivity from the start, producing superior candidates in fewer design rounds. Identifying better starting points for AI-led chemistry eliminates bottlenecks in the hit to candidate optimization phase. Generating better Enzyme Inhibitors by targeting Quantum Transition States. We work with enzyme inhibitors in a unique way, continually developing …

Type: SMB Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Synthetic Biology

Lung Cancer Research The Spanish lung cancer (GECP) group is a cooperative work and research group in this pathology formed by more than 460 professionals who enjoys a high positioning both nationally and internationally. Research to achieve more effective treatments against the disease is one of the main missions and values ​​of the GECP. A work that develops from its administrative headquarters. Since its implementation, the headquarters of the GECP has led, developed and monitored studies and essays in different clinical situations, from initial stages of the disease, to the most advanced, in which more than 18,000 patients have been …

Type: SMB Activities: deeptech Technologies: Synthetic Biology

Next generation medical devices. Kenota Health makes allergy testing safe, simple and certain. Kenota Health develops next generation medical diagnostic tools. We make allergy testing safe, simple and certain. Diagnostics, Medical Technology, Point of Care, and Allergy

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Nature experience & amp; Health Men and women in the service of health and well-being Pharmacy, parapharmacy, dermatology, cosmetics, dietetics, veterinary products, infants, food supplements, phytoterapy, and drugs

Type: SMB Activities: healthtech Technologies: Synthetic Biology

Leading the Next Frontier of Cell Therapy Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system. Founded by pioneers in Treg biology and cell therapy, the company is employing proprietary platform technologies and approaches to develop a new generation of targeted Treg cell therapies designed to induce durable immune tolerance to treat and prevent autoimmune and inflammatory diseases. Sonoma Biotherapeutics is based in South San Francisco and Seattle. cell therapy and autoimmune disease

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

20 years saving Asia's dogs & cats through rescue, CNVR, treatment, shelter, adoption & ending the dog & cat meat trade Soi Dog’s mission is 'To improve the welfare of dogs and cats in Asia, resulting in better lives for both the animal and human communities, to create a society without homeless animals and to ultimately end animal cruelty'. Established in 2003 in Phuket, Thailand, Soi Dog is Southeast Asia's largest organisation helping stray animals. The sanctuary in Phuket is currently home to over 1,800 animals. Soi Dog also has a treatment facility in Bangkok and responds to crisis situations …

Type: SMB Activities: pettech healthtech Technologies: Synthetic Biology

Innovation for people Created in 1963, Farmaindustria is the National Association of the Pharmaceutical Industry established in Spain. It brings together most of the innovative pharmaceutical laboratories established in Spain, which accounts for almost all sales of prescription drugs under patent in the country. farmacia, investigación y desarrollo, industria, innovación, salud, sanidad, health, pharma, healthcare, laboratorios, medicamentos, fármacos, pharmaceuticals, medicine, I+D, vacunas, vaccines, and industria farmacéutica

Type: SMB Activities: healthtech deeptech biotech Technologies: Synthetic Biology

From replacement to regeneration osteobionix is a company dedicated to advancing the standards of care for people suffering from cartilage or bone loss. Cartilage and bone loss may result from a variety of causes including osteoarthritis, trauma and tumor and can severely affect a person’s lifestyle. osteobionix wants to provide people suffering from cartilage or bone loss with innovative, high quality, proven, customized solutions, which can help them regain the lifestyle they deserve. osteobionix collaborates with surgeons in designing and manufacturing reliable, cost-effective solutions, which take into account the uniqueness and complexity of each single surgical case. osteobionix strives to …

Type: SMB Activities: deeptech manufacturing Technologies: 3D Printing Synthetic Biology

We are the employer of the pharmaceutical industry of generic medicines in Spain. AESEG is the employer of the pharmaceutical industry of generic drugs in Spain and the qualified business interlocutor in this area. AeseG members can be all those laboratories of pharmaceutical specialties, manufacturing companies of raw materials and active pharmaceutical ingredients or technological development companies whose main activity is developed in the field of generic ones inside the national territory. AESEG became Barcelona on March 17, 1998 as a non -profit national organization, to boost the knowledge and use of generic medicines, creating a true culture of generic …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Spanish Society of Medical Radiology (SERAM) SERAM is a medical-scientific and professional organization dedicated to promoting among its partners the teaching, development, defense and research of all diagnostic and therapeutic aspects related to the medical image, making its activities known to the general population. Radiodiagnosis, Radiology, and Image Diagnosis

Type: SMB Activities: healthtech Technologies: Synthetic Biology

Biopredic International is committed to support Life Science Research by developing and distributing biological tools. We assist both academia and industries in drug development, drug discovery, cosmetic and chemical fields. Biopredic International delivers assays, tissues, cells and reagents including: > High quality hepatocytes (human and animal, fresh or cryopreserved) and other liver-derived products (microsomes, S9 fractions and cytosols) > Skin products (fresh or frozen), including human skin discs and skin sheets (full thickness, dermatomed, stratum corneum), skin cells (keratinocytes, fibroblasts), subcellular fractions... > Blood products, including whole blood, sera, plasma, PBMCs, lymphocytes, monocytes, dendritic cells, CD34... > And other products …

Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology